In our laboratory, we are preparing a list of practical experiments that could be performed to directly test both IL-37 and IL-38 in breast cancer models (tumor cells, co-cultures with macrophages and lymphocytes) using these recombinant anti-inflammatory cytokines. Here, IL37 is linked to breast cancer.